These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20801938)

  • 1. Riociguat (BAY 63-2521) and warfarin: a pharmacodynamic and pharmacokinetic interaction study.
    Frey R; Mück W; Kirschbaum N; Krätzschmar J; Weimann G; Wensing G
    J Clin Pharmacol; 2011 Jul; 51(7):1051-60. PubMed ID: 20801938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat in Healthy Young Chinese Male Non-Smokers and Smokers: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
    Zhao X; Wang Z; Wang Y; Zhang H; Blode H; Yoshikawa K; Becker C; Unger S; Frey R; Cui Y
    Clin Pharmacokinet; 2016 May; 55(5):615-24. PubMed ID: 26507720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males.
    Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Middle MV
    Arzneimittelforschung; 1996 Jan; 46(1):41-6. PubMed ID: 8821516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers.
    Rahimy M; Hallén B; Narang P
    Arzneimittelforschung; 2002; 52(12):890-5. PubMed ID: 12572529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat.
    Frey R; Becker C; Saleh S; Unger S; van der Mey D; Mück W
    Clin Pharmacokinet; 2018 Jun; 57(6):647-661. PubMed ID: 29086344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinacalcet does not affect the pharmacokinetics or pharmacodynamics of warfarin.
    Padhi D; Sullivan JT
    Drugs R D; 2007; 8(2):79-87. PubMed ID: 17324005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension.
    Grimminger F; Weimann G; Frey R; Voswinckel R; Thamm M; Bölkow D; Weissmann N; Mück W; Unger S; Wensing G; Schermuly RT; Ghofrani HA
    Eur Respir J; 2009 Apr; 33(4):785-92. PubMed ID: 19129292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin.
    Kong AN; Tomasko L; Waldman SA; Osborne B; Deutsch PJ; Goldberg MR; Bjornsson TD
    J Clin Pharmacol; 1995 Oct; 35(10):1008-15. PubMed ID: 8568008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
    Belik J
    Curr Opin Investig Drugs; 2009 Sep; 10(9):971-9. PubMed ID: 19705340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riociguat: a novel new drug for treatment of pulmonary hypertension.
    Makowski CT; Rissmiller RW; Bullington WM
    Pharmacotherapy; 2015 May; 35(5):502-19. PubMed ID: 26011143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
    Gu N; Kim BH; Lim KS; Kim SE; Nam WS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the soluble guanylate cyclase stimulator riociguat on memory performance in healthy volunteers with a biperiden-induced memory impairment.
    Borghans LGJM; Sambeth A; Prickaerts J; Ramaekers JG; Blokland A
    Psychopharmacology (Berl); 2018 Aug; 235(8):2407-2416. PubMed ID: 29882087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarin.
    Mallikaarjun S; Bramer SL
    Clin Pharmacokinet; 1999; 37 Suppl 2():79-86. PubMed ID: 10702890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.
    Oberwittler H; Hirschfeld-Warneken A; Wesch R; Willerich H; Teichert L; Lehr KH; Ding R; Haefeli WE; Mikus G
    J Clin Pharmacol; 2007 Jan; 47(1):70-7. PubMed ID: 17192504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.
    Tiseo PJ; Foley K; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):45-50. PubMed ID: 9839766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects.
    Csonka D; Bruderer S; Schultz A; Soergel M; Stepanova R; Sabattini G; Perez-Ruixo JJ
    Clin Drug Investig; 2019 Dec; 39(12):1223-1232. PubMed ID: 31552642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers.
    Liao S; Palmer M; Fowler C; Nayak RK
    J Clin Pharmacol; 1996 Nov; 36(11):1072-7. PubMed ID: 8973996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riociguat (BAY 63-2521) and aspirin: a randomized, pharmacodynamic, and pharmacokinetic interaction study.
    Frey R; Reber M; Krätzschmar J; Unger S; Mück W; Wensing G
    Pulm Circ; 2016 Mar; 6(Suppl 1):S35-42. PubMed ID: 27162625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of pharmacokinetic and pharmacodynamic interactions of roflumilast with (R, S)-warfarin in healthy adult subjects.
    McCracken N; Lahu G; Bethke TD
    Int J Clin Pharmacol Ther; 2011 Jun; 49(6):388-96. PubMed ID: 21612746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.